Brief: Lee's Pharmaceutical Says Unit Entered Binding LOI
08/05/2020 12:37
May 8 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* -UNIT ENTERED BINDING LOI FOR RIGHTS TO DEVELOP,
MANUFACTURE,
COMMERCIALISE IC-265 & IC-270 IN CHINA & SOUTHEAST ASIA
Source text for Eikon: ID:nHKS1b3cnz
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA